Progesterone Treatment in Female Smokers - 12
Completed · Phase 2
Conditions studied: Tobacco Use Disorder
In brief
The purpose of this study is to investigate progesterone effects in female smokers
Key facts
- Study ID
- NCT00000295
- Run by
- National Institute on Drug Abuse (NIDA)
- People needed
- 0
- Starts
- 1999-04-01
- Expected to finish
- 2001-12-01
- Last updated by the study team
- 2017-01-12
Who can join
Age: 21 and older, up to 45. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Female subjects aged 21-45 years with a smoking history of at least 20 cigarettes daily for at least 1 year. In good health as verified by medical history, screening examination, and screening laboratory tests. Not pregnant as determined by pregnancy screening nor breast feeding, and using acceptable birth control methods other than hormonal contraceptives.
You may not qualify if…
- History of heart disease, peripheral vascular disease, COPD, liver diseases, abnormal vaginal bleeding, suspected or known breast malignancy, or any other medical condition which physician investigator deems inappropriate for subject participation. Use of regular psychotropic medication (antidepressants, antipsychotics, or anxiolytics) and recent psychiatric history. Amenorrhea. Current use of oral or other types of hormonal contraceptives. Abuse of alcohol or any other recreational or prescription drug. Regular use of any other tobacco products, including smokeless tobacco and nicotine products. Known allergy to progesterone or peanuts.
Where it is running
- University of Minnesota — Minneapolis, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.